Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS author centre
    • COVID-19 submission information
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS author centre
    • COVID-19 submission information
  • Alerts
  • Subscriptions
A.B. Cortot
European Respiratory Review 2015 24: 157; DOI:
A.B. Cortot
Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading
Fighting Lung Cancer through the HER Family of Surface Receptors Edited by Diego Márquez-Medina Published by Nova Science Publishers Inc. Pages: 311. Price: £123.00. ISBN: 978-1-63321-092-9
Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Treatment of lung cancer has evolved considerably over the past few years thanks to a better understanding of the molecular mechanisms involved in lung carcinogenesis, and the development of new drugs that are able to inhibit specific key signalling pathways within the cancer cell. The best illustration of this (r)evolution is the story of epidermal growth factor receptor (EGFR or HER1) inhibitors, which have become the cornerstone for the treatment of EGFR-mutated lung cancers. These drugs were initially thought to yield modest benefit in the overall population of nonsmall cell lung cancer (NSCLC) patients, but the discovery of EGFR mutations revealed a unique model of oncogene addiction in lung cancer associated with exquisite sensitivity to EGFR inhibition. However, many questions remain on the management and treatment of NSCLC, especially regarding EGFR and other HER family members. How should we screen for EGFR mutations? Can we use other biomarkers for predicting efficacy of HER inhibitors? Why don't all the patients with EGFR-mutated NSCLC respond to EGFR tyrosine kinase inhibitors (TKIs)? How should we manage acquired resistance to EGFR TKIs?

This book provides key data for discussing and answering these questions and has gathered together more than 30 experts in lung cancer biology and treatment, most of them belonging to the Spanish Lung Cancer Group which has sponsored important studies in this field. The book is divided into eight parts including: an overview on epidemiology; biology of lung cancer with a focus on deregulation of HER receptors; laboratory processes regarding HER-related biomarkers; timing for biomarker testing; treatment with HER inhibitors; resistance to HER inhibitors; perspectives in the treatment of lung cancer; and a brief overview on the use of HER inhibitors in other malignancies.

Overall, this book provides comprehensive information on the current knowledge of HER receptor biology and its role in the genesis and treatment of lung cancer. Some chapters have attracted particular interest. The chapter dedicated to the techniques for detection of EGFR mutations is well detailed which will be useful for clinicians struggling to understanding how all these techniques work, although it would have been interesting to discuss new technologies further, such as the detection of EGFR mutations in circulating DNA. The chapter on the management of resistance to EGFR TKIs is also very well documented and provides all the molecular and clinical data on this hot topic, which represents the next big challenge, i.e. fighting resistance to EGFR inhibitors. Finally, the chapters dealing with other malignancies such as breast cancer, head and neck cancer or cancers of the digestive tract increase our understanding of the role of HER receptors in cancer and open new perspectives for the treatment of lung cancer. Thus, this book will serve as a valuable tool for juniors and experienced clinicians and researchers seeking a comprehensive review on HER receptors in lung cancer.

  • Copyright ©ERS 2015.
PreviousNext
Back to top
View this article with LENS
Vol 24 Issue 135 Table of Contents
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
A.B. Cortot
European Respiratory Review Mar 2015, 24 (135) 157;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
A.B. Cortot
European Respiratory Review Mar 2015, 24 (135) 157;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Asthma: Comorbidities, Coexisting Conditions, and Diff erential Diagnosis
Show more Book review

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2021 by the European Respiratory Society